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Abstract The increasing threat of antimicrobial resistance
poses one of the greatest challenges to modern medicine.
The collection of all antimicrobial resistance genes carried
by various microorganisms in the human body is called the
human resistome and represents the source of resistance in
pathogens that can eventually cause life-threatening and
untreatable infections. A deep understanding of the human
resistome and its multilateral interaction with various environ-
ments is necessary for developing proper measures that can
efficiently reduce the spread of resistance. However, the hu-
man resistome and its evolution still remain, for the most part,
a mystery to researchers. Metagenomics, particularly in com-
bination with next-generation-sequencing technology, pro-
vides a powerful methodological approach for studying the
human microbiome as well as the pathogenome, the virolume
and especially the resistome. We summarize below current
knowledge on how the human resistome is shaped and discuss
how metagenomics can be employed to improve our under-
standing of these complex processes, particularly as regards a
rapid translation of new findings into clinical diagnostics, in-
fection control and public health.
Keywords Antimicrobial resistance . Antibiotic selection
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Introduction
The increasing numbers of infections caused by multi-drug re-
sistant (MDR) bacteria have developed into a global and acute
public health crisis [1]. The implementation of antimicrobial
stewardship programs as well as the development of novel anti-
infectives has become a primary focus of public health and re-
search activities in order to reduce the burden of infections
caused by MDR pathogens [2]. New mechanisms mediating
antimicrobial resistance against antibiotics in the Blast line of
defence^ are steadily reported from all over the world, leaving
us only limited therapeutic options for treating serious infections
[3]. It is important to understand that human beings can be the
vessel in which antimicrobial resistance is born or by which it is
spread. The human body harbours at various sites a complex
microbial ecosystem and represents a vast reservoir for antimi-
crobial resistance genes (ARGs), referred to in their totality as the
human Bresistome^ [4]. This human resistome is an open and
dynamic entity, shaped by several extrinsic and intrinsic factors
that massively interact with each other [5–14] (Fig. 1). To com-
prehend these interactions, researchers must utilize the full spec-
trum of modern technology available in our scientific arsenal,
and they must start with the study of the bacterial, viral, parasitic
and fungal genetic material that is derived from human body
sites. Such a methodological approach is termed metagenomics.
In this review, we present an overview of current knowledge
on the human resistome. We also outline how metagenomics
may be used to characterize the human resistome and how newly
acquired insights can be rapidly transferred to clinical microbiol-
ogy and infection control for practical implementation. We call
this approach translational metagenomics.
Functional metagenomics and the human resistome
Conventional approaches used to determine antimicrobial re-
sistance in bacteria usually rely on a culture-based
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methodology and focus almost exclusively on human patho-
gens. Since only a minority of bacterial organisms can be
cultured [15–17], and since most of these non-pathogenic
commensals are thought to constitute an important resistance
gene pool that can be transmitted to human pathogens [18], we
need to extend the methodological spectrum for detection of
ARGs. Non-culture-based approaches such as metagenomics
can overcome these common limitations [19, 20]. Two major
techniques used thus far include both functional and
sequence-based metagenomics.
The primary strength of functional metagenomics is its
ability to detect novel and highly divergent ARGs on a large
scale [21]. New ARGs have been discovered every year in the
last decade, reflecting a relentless global evolution of a mag-
nitude we have yet to comprehend. Therefore, efforts to detect
novel ARGs must be one of the major goals of research if we
are to limit the danger of resistance. Our knowledge here can
serve as the fundamental basis for developing efficient
countermeasures.
In functional metagenomics, DNA is extracted from a ma-
terial of interest and fragments are cloned into vectors that
differ in terms of the feasible insert size of the DNA fragment
[22]. Vectors like the pUC family plasmids accept inserts of
only small sizes (<10 kb) but do provide a high copy number
while using the host’s transcription and translation system.
Other vectors like fosmids (25–45 kb inserts), cosmids (15–
40 kb inserts) or bacterial artificial chromosomes (100–200 kb
inserts) can harbour larger fragments, allowing for a more
detailed investigation of the ARG’s genomic environment,
e.g. in determining species origin or vicinity to mobile genetic
elements. However, such vectors exist in lower copy numbers,
and gene recognition by the host organism can be inefficient
[23]. The metagenomic library is then transformed into an
expression host such as Escherichia coli. The host is cultured
on selective media and the inserts of antibiotic resistant clones
are sequenced either by using the Sanger or next-generation
sequencingmethod. The genes thus identified can subsequent-
ly be associated with the observed phenotype [21, 24].
Functional metagenomics has been applied in several in-
formative studies that investigated the composition of the hu-
man resistome. Sommers et al. isolated DNA from faeces and
saliva of two healthy individuals [25]. Identified ARGs from
the mostly anaerobic microflora had only low similarity to
known ARGs from pathogenic isolates (54.9 % at amino acid
level), while 95 % of ARGs from an aerobic cultured subset
were over 90 % identical to known ARGs from pathogens,
suggesting a genetic barrier between commensals and patho-
gens. These results are astonishing since it is thought that the
spread of ARGs between bacterial species is mainly driven by
a process called horizontal gene transfer (HGT). HGT primar-
ily occurs through the exchange of conjugated plasmids
(conjugation) or the exchange of genetic material by bacterio-
phages (transduction) [26]. The results from Sommers at al.
indicate a relatively low HGT frequency. However, both vol-
unteers in the study had not received antibiotics for at least
1 year, a fact that must be taken into consideration when
interpreting these results.
Another study offering insights into the development of the
gut resistome investigated metagenomic libraries from faecal
DNA of healthy infants and children with almost no history of
antibiotic exposure [27]. Functional analysis for resistance to
18 antibiotics was performed and revealed a diverse spectrum
of novel as well as already documented ARGs in the guts of
the infants, even in the absence of selective forces. Of note
was the observation of the genes TetX1 and TetX2 that are
suspected to confer resistance to tigecycline, which is consid-
ered to be a reserve antibiotic agent. The abundance of ARGs
in the guts of the infants points to an early establishment of the
human gut resistome, possibly supported by a transfer of
ARG-harbouring species directly from the mother to the child
in combination with early contact to external non-human
sources of resistance. A pooled metagenomic library from
22 antibiotic-naïve, 6-month-old infants has confirmed these
results by revealing the finding of various aminoglycoside and
β-lactam resistance genes with a high homology to commen-
sals’ ARGs [28].
Apart from the extensively studied faecal resistome, the
oral microbiota also acts as an important pool of ARGs and
is a primary gateway for the acquisition of resistant bacteria
[29, 30]. In one study, metagenomes from faeces as well as
oral specimens were analysed to determine the frequency dis-
tribution of tetracycline and erythromycin resistance genes.
The results revealed that tet(M) was frequent in the oral mi-
crobiota while erm genes were present at much lower quanti-
ties [31]. Another metagenomic library constructed from
Fig. 1 Potential factors shaping the human resistome
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human oral cavity samples contained tet37, a novel tetracy-
cline resistance gene [32]. The same group of researchers ap-
plied functional metagenomics in studying samples of the oral
microbiota from 60 adult volunteers [33], detecting amoxicil-
lin and tetracycline resistance elements. The authors though
did not provide information about history of antibiotic use.
The influence of antibiotics on the oral resistome is still a
matter of debate. Clemente et al. found 28 ARGs in the oral
microbiome of an antibiotic-naïve Amerindian population, in-
cluding genes conferring resistance to third-generation ceph-
alosporins [34]. Most of these ARGs exhibited a high similar-
ity (>95%) to genes in the HumanMicrobiome Project, which
largely contains data from populations that are regularly ex-
posed to commercial antibiotics. Whether the influence of
non-anthropogenic antibiotics or other factors could explain
this phenomenon remains unclear at this point.
Despite the great methodological advantages of functional
metagenomics, some serious limitations exist as well [35, 36]:
(i) The bacterial host must fit to the experimental setting.
Screening for a certain antibiotic resistance is only possible
if the host is not intrinsically resistant to the antibiotic. (ii)
Results fundamentally depend on the host’s ability to express
the cloned genes. Using only one bacterial host, as found in
the majority of studies (mostly E. coli), might thus lead to a
fairly underrepresented picture of the human resistome. (iii)
The use of different media and incubation conditions make a
direct comparison between studies difficult. (iv) Accurate
quantification of ARGs is not possible. This can hamper the
investigation of antibiotic influences, e.g. in determining se-
lection pressure. (v) The choice of the insert size is an impor-
tant factor. Resistance to antibiotics might be encoded bymul-
tiple genes rather than single genes, and short inserts are for
the most part not able to provide such a degree of complexity,
while larger inserts can have low levels of expression. (iv)
Finally, the functional metagenomics approach is labour-
intensive and, at present, does not provide the option of
high-throughput measurements.
Sequence-based metagenomics and the human
resistome
As with functional metagenomics, the sequence-based ap-
proach involves extracting DNA directly from human, animal
or environmental samples, including those from unculturable
microorganisms. According to their sizes, eukaryotic cells,
bacteria and viruses can be separated using filtration or cen-
trifugation before genomic DNA is extracted. Subsequently,
the once time-consuming procedure of genomic DNA se-
quencing is carried out. The development of next-generation
sequencing technologies over the past 10 years has dramati-
cally increased the sequencing capabilities and thereby
opened a new portal to sequence-based research [37]. The
application of shotgun metagenomics allows the generation
of millions of DNA or RNA sequences from a sample without
the need for prior amplification of a specific target gene [38].
This forms the basis for an unbiased determination of the
microbial and functional composition of specimens from any
human body site as well as for the characterization and quan-
tification of the respective resistome [38–41]. Sequencing is
followed by mapping the metagenomic reads against a cata-
logue of known sequences usually from national and interna-
tional databases. The choice of databases depends on whether
a functional or taxonomic analysis has priority. Databases that
consist of a collection of ARGs include CARD [42], ARG-
ANNOT [43], ARDB [44], RED-DB (http://www.fibim.unisi.
it/REDDB/), ResFinder [45] or Resfams [46]. Reads that map
with a high degree of confidence against specific genes like
ARGs can then be counted and thus quantified. Alternatively,
reads can be assembled into contigs, and the function of
identified genes can be predicted by comparing them with
database sequences that have functional annotations. A
general comparison between functional and sequence-based
metagenomics is presented in Table 1.
Sequence-based metagenomics has been applied in
several studies that investigated the structure and devel-
opment of the human bacterial resistome. An analysis of
a human dental plaque revealed that 2.8 % of all predict-
ed genes from the metagenome assembly encoded for
resistance to antibiotic or toxic compounds, an astonish-
ingly high number that suggests that the oral cavity is
indeed an important reservoir for ARGs [47].
The intestinal resistome, as opposed to the resistomes from
other body parts, has been studied extensively. Forslund et al.
conducted a comprehensive study by analysing 252 intestinal
metagenomes from the USA, Denmark and Spain [48]. ARGs
were identified by using the ARDB reference collection [44]
after manual augmentation. The authors defined the term
Bantibiotic resistance potential^ as a measure that was based
on the abundance of resistance genes relative to the genetic
material from species where resistance genes were identified.
The antibiotic resistance potential (ARP) revealed geographic
differences, with Spain having the highest mean ARP in the
majority of antibiotics. However, these data largely indicate a
trend, as the Spanish ARP interquartile range overlapped for
the most part with the ARPs from the US and Denmark, mak-
ing it difficult to draw a final conclusion from these results.
Interestingly, ARPs for antibiotics that are approved for ani-
mal use by the U.S. FDAwere significantly higher when com-
pared to antibiotics not approved for animal use, suggesting
that the administration of antibiotics in animals promotes the
development of resistance in the human intestinal microbiota.
Including additional samples from France and Italy revealed
that the country-specific ARPs correlated with higher outpa-
tient antibiotic usage in Europe, but the application of different
sequencing strategies in the individual country datasets
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presents too much of a technical challenge for any fair compar-
ison to be made. The same methodology was used in another
survey, revealing that ARPs of Chinese samples were even
higher for many antibiotics than the Western samples [11].
These results were confirmed by Hu et al., who found 1093
ARGs in the intestinal metagenomic samples of 162 individuals,
with the highest relative abundance of ARGs in the Chinese
dataset, followed by the Danish and Spanish datasets [40]. A
neighbourhood-joining tree based on SNPs in antibiotic resis-
tance genes clustered the Danish and Spanish population but
separated the Chinese samples, probably reflecting distinct gene
variants attributed to differences in the microbiota and in the
antibiotic usage of the different populations.
It is noteworthy that, apart from being localized in the bac-
terial genome, ARGs might be incorporated in the genome of
bacteriophages. Bacteriophages are DNA and RNAviruses that
infect bacteria and form a major part of the human gut virome
[49]. Bacteriophages act as vehicles for horizontal gene transfer
between bacteria via a process referred to as transduction. In
comparison to plasmids, bacteriophages can persist in the en-
vironment, and the transfer of genetic material does not require
the donor bacterium and recipient bacterium to be present in the
same environment at the same time. This has led to the
hypothesis that bacteriophages might frequently act as vehicles
for resistance transfer and are independent reservoirs for anti-
microbial resistance [50–54]. Bacteriophages can be encoun-
tered everywhere in the environment and are highly abundant
in water, coastal sediments and soil samples [55].
In the human gut, virus-like particles (VLPs) including
bacteriophages seem to be prevalent in a number comparable
to the amount of bacteria at this site. The analysis of VLPs in
human faeces from five individuals indicated levels of approx-
imately 108–109 VLPs per gramme faeces [56]. ARGs in bac-
teriophages can be detected by quantitative real-time PCR ([6,
9, 57]), as demonstrated in a study in which the presence of
clinically relevant resistance genes was determined in the bac-
teriophage fraction of stool samples from 80 healthy individ-
uals. In 77 % of the samples, at least one ARG could be
detected. The ß-lactamases TEM and CTX-M-1 genes were
the most abundant [58].
Sequence-based metagenomics allows an even broader
range of phage-derived ARGs to be detected, given we have a
successful and specific extraction of viral DNA prior to se-
quencing. A broad range of ARGswas detected at different time
points in human intestinal viral metagenome sequences from six
and five individuals, respectively. ARGs included multidrug





• Detection of unknown antimicrobial resistance genes
possible
• Immediate association between identified gene and
resistance phenotype
• Detailed investigation of the genomic environment is
highly accurate (with large insert fragments)
•Results depend on the host’s ability to express a gene
• Intrinsic resistance of the host reduces the spectrum
of screening for resistance genes
• Study results can be hard to compare due to different
media and experimental conditions
• Short insert sizes can result in underestimation of a





• Mapping of sequence reads to resistance databases
allows to detection of even low abundance ARGs
• Several methods for ARG abundance calculation
exist as a requirement for determination of selection
pressure
• Relatively low time-consuming methodology, suit-
able for high throughput experiments
• Raw data can be re-analysed after database updates
and allow thus the detection of Bnovel^ ARGs
• Beside a resistome analysis, it is possible to analyse
the taxonomic and metabolic composition of a
sample all at once
• ARGs highly dissimilar to sequences in databases
cannot be detected (high database dependency)
• No functional confirmation that a gene would
actually confer the predicted resistance, only a
reflection of its potential
• Investigation of the genomic environment of an
ARG is less reliable since usually based on a
metagenomic assembly that is still not a
standardized procedure
• Short reads might accidently align to ARGs when
using less stringent mapping parameters
• No standard criteria for pre-analytics, DNA
extraction, sequencing and bioinformatic analysis
available
ARG antimicrobial resistance gene
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efflux transporters, tetracycline and vancomycin resistance
genes, and ß-lactamases [59, 60].
Viruses from other body sites also seem to contribute signif-
icantly to the human resistome. ARGs mediating resistance to ß-
lactams, vancomycin, aminoglycosides,macrolides, tetracyclines
and chloramphenicol were detected in viral metagenome se-
quences from the saliva of five individuals sampled at different
time points [60]. Another analysis of five metagenomic virome
datasets of sputum samples from cystic fibrosis patients found
evidence for an increased abundance of various ARGs when
compared to datasets of individuals without disease [61]. In a
recent study, the human skin virome of 16 healthy volunteers
was analysed at two time points. The isolated VLPs contained
29 unique ARG groups relating to ß-lactamases, efflux pumps,
rifampicin and tetracyclines resistance. Approximately half of the
identified ARGs were located on contigs that additionally
contained phage-associated genes [62].
The data available on the human virome and resistance
genes in VLPs are based on only a few studies with small
sample sizes. We need more information on phage-host inter-
action in order for us to understand the mechanisms and dy-
namics of ARG transfer between commensals and pathogens
and howmuch phage activity does contribute to the shaping of
the human resistome, particularly under antibiotic treatment.
While sequence-based metagenomics is a promising ap-
proach, particularly in determining the abundance of ARGs,
it also has the following limitations: (i) Functional
metagenomic studies showed a high number of ARGs with
no significant similarity to sequenced genes deposed in data-
bases. Such novel sequences cannot easily be identified using
sequence-based metagenomics, and the resistance potential of
a sample might be severely underestimated. (ii) Functional
confirmation in terms of whether a gene is expressed and
can actually confer resistance or whether it simply encodes
an alternative function in the given host is not provided.
Metatranscriptomics or proteomics might provide additional
information [22, 63, 64], but these should be combined with
DNA sequencing, as the actual protein expression could sim-
ply indicate a momentary appearance. Of note, some degree of
variation can also be expected in DNA sequencing [65]. (iii)
Mapping of reads to reference sequences usually provides
only limited information on the genetic environment of the
ARG. However, information about the host species, or wheth-
er a gene is located on a mobile genetic element, can offer
important insights regarding the clinical relevance of an ARG.
A solution could be a metagenomic assembly of the sample,
but there are no standard criteria to assess the success of such a
complex analytical process [66–69].
Despite these limitations, the application of sequence-
based metagenomics offers a wide range of possibilities in
diagnostics, infection control and research since the technolo-
gy is capable of exploring the taxonomic composition, ARG
abundance and the functional profile of a sample all at once.
Translational metagenomics in clinical diagnostics
Sequence-based metagenomics in clinical microbiology diag-
nostics is seen as a method offering great potential for the
future, not only for the examination of the human resistome
but also for the detection of human pathogens, among others.
The approach does not require a priori knowledge of the ex-
pected pathogen. It enables the detection of co-infections [70]
and can provide information on the host response in the case
of RNA sequencing [71]. Several reports describing the use of
sequence-based metagenomics to resolve cases involving un-
clear infectious diseases have demonstrated the advantages of
the method for clinical diagnostics [72–76]. In addition, the
technique can be applied in outbreak situations to identify the
causative agent [77, 78], including novel infectious agents
[79], while also providing phylogenetic information on the
organisms involved in infections [72, 80].
Besides identifying pathogens, appropriate patient man-
agement depends on correct and fast antimicrobial suscepti-
bility testing results. Despite being promising, only a few
studies have used sequence-based metagenomics to identify
and characterize the resistance pattern of a pathogen. One
study compared RNA metagenomic sequencing with conven-
tional diagnostics in influenza-positive respiratory specimens
from 24 patients. The presence of resistance markers in the
hemagglutinin (HA) and neuraminidase gene was evaluated in
a subset of 6 samples. Mutations that are associated with me-
dium resistance to zanamivir and with resistance to
adamantane were detected in the neuraminidase gene. All
strains were predicted to be susceptible to oseltamivir and
peramivir due to the absence of known resistance markers
[70]. The utility of sequence-based metagenomics in this con-
text is supported by Graf et al., who compared metagenomics
RNA sequences obtained from paediatric nasopharyngeal
swabs with a commercial respiratory PCR panel. Sufficient
sequencing coverage of the neuraminidase gene was obtained
in 6 out of 8 H1N1 influenza-positive samples. The
oseltamivir resistance marker H275Y was not detected in
any of the six samples [81]. In a study conducted in South
Africa, the authors were able to determine the frequency of
minor variant HIV drug resistance mutations in infected new-
borns [82].
Sequence-based metagenomics has also been applied to
detect bacterial ARGs in clinical settings. Conventional mi-
crobiological culture was compared to whole-genome se-
quencing (WGS) of bacterial isolates and sequence-based
metagenomics from 35 urine samples [83]. The predicted re-
sistance phenotype obtained from WGS data and
metagenomics data correlated surprisingly well with the con-
ventional antimicrobial resistance pattern of the isolates.
However, in two samples, more ARGs were obtained by
metagenomics compared to the WGS dataset. In addition,
ARGs were also present in two of four culture-negative
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samples, most likely originating from urinary tract flora or
unculturable organisms.
The investigation of Clostridium difficile positive stool
samples and five stool samples from healthy controls re-
vealed that class A Beta-lactamase genes and tetracycline
ARGs were most abundant, followed by macrolide ARGs
[84]. However, the authors could not determine the bacte-
rial species from which the ARGs originated, which limits
the value of these results. In another study, investigating
the utility of sequence-based metagenomics in patients suf-
fering from Mycobacterium tuberculosis infections, eight
smear-positive sputum samples were analysed. In seven
samples, metagenomic sequencing data allowed the iden-
t i f i ca t ion of the spec ie s and l inage wi th in the
M. tuberculosis complex. However, no prediction of the
susceptibility patterns of the Mycobacteria could be drawn
from the data, most likely due to the insufficient coverage
depth of M. tuberculosis in the sputum sample [85].
A recent study used sequence-based metagenomics to
detect free-circulating DNA from plasma samples of sep-
tic patients [86]. The authors analysed 62 samples from
seven sepsis patients, six patients who underwent abdom-
inal surgery and 12 healthy volunteers at different time
points. Quantitative evaluation of non-human reads and
the introduction of a sepsis indicating quantifier score
enabled the identification of the sepsis-causing agents.
The results matched perfectly with the organisms recov-
ered from the blood cultures in these patients. In one
patient who suffered from sepsis after liver transplanta-
tion, Enterococcus faecium reads and hits for the resis-
tance genes vanB, vanSB, tetl and sta4 were identified.
A vancomycin-resistant E. faecium could be recovered
from the patient’s blood cultures, demonstrating the use-
fulness of the methodology, particularly in sepsis, which
is often caused by a single bacterium, a situation that
increases the likelihood that a detected ARG originates
from the respective pathogen.
All reports of clinical application of sequence-based
metagenomics are individual cases or small-scale investiga-
tions, limited through their size in providing answers to some
essential questions. Before implementing sequence-based
metagenomics for identifying pathogens and predicting their
antimicrobial susceptibility patterns, we need to establish stan-
dardized operation procedures for different clinical specimens.
Standardization needs to take the following factors into ac-
count: (i) the resident flora, (ii) the sequencing depth required
to achieve a defined coverage as well as (iii) the length of a
sequence read that is needed to determine the taxonomic ori-
gin of ARGs. Lastly, the lack of applicable regulatory guide-
lines for the implementation of sequence-basedmetagenomics
in routine diagnostics hampers its integration in clinical mi-
crobiology diagnostics [19], a legal issue that should be re-
solved in the near future.
Translational metagenomics in determining
antibiotic treatment impact
Some research groups have recently addressed the question of
how metagenomics can be used to determine the impact of
administering antibiotics on the intestinal resistome in patients
or volunteers [39, 41]. Information about the selective force of
antibiotics is crucial as it enables clinicians directly to com-
pare different drug regimens and to decide on which drug or
drug combination should be preferred over others due to a
lower influence on the resistome of their patients. Such strat-
egies applied in antibiotic stewardship programs could offer
efficient ways in reducing the spread of multidrug resistance.
Determining selection pressure is fundamentally based on a
genuine quantification of ARGs. Several quantification efforts
have been applied and published. Buelow et al. investigated
the impact of selective digestive decontamination (SDD) on
the gut’s resistome in critically ill patients [41]. SDD involved
a regime that consisted of colistin, tobramycin, a third-
generation cephalosporin and amphotericin B. Under treat-
ment, the authors observed an 6.7-fold increase in the abun-
dance of aminoglycoside resistance genes, particularly for
aph(2″)-Ib and an aadE-like gene. They used a metagenomic
assembly strategy for ARG quantification. In a local Blast
search, a clustered version of the Resistance Determinants
Database (RED-DB; http://www.fibim.unisi.it/REDDB/) was
used as a query to find ARG on assembled contigs. A log-
transformed quotient of the coverage of a contig encoding an
ARG over the average sequencing depth of the total assembly
was then determined as a value reflecting the relative abun-
dance.While this is a valid estimation of the ARG content, it is
primarily based on the quality of the metagenomic assembly
and is likely to overlook ARGs in low quantities, since they
usually fail to be assembled. Moreover, the authors of the
study have reported issues with small contig size preventing
a detailed investigation of the genomic environment of ARGs.
Therefore, they have constructed fosmid libraries with inserts
of about 40 kb and found ARG sequences associated with
phage-, plasmid or IS element structures and with anaerobes
from the phyla Firmicutes (Subdoligranulum, Clostridia),
Bacteroidetes (Bacteroides uniformis) and Actinobacteria as
species origin. An estimate of the selective force caused by the
SDD regime was not calculated.
Recently, our group developed an analysis pipeline to de-
termine selective pressure by using sequence-based
metagenomics in two volunteers receiving ciprofloxacin
[39]. We compared different ARG abundance calculations,
all based on the mapping of 100-bp-long sequence reads to
either the Comprehensive Antibiotic Resistance Database
(CARD) [42] or a non-redundant protein catalogue consisting
of sample specific proteins, RefSeq proteins and CARD. We
observed a generally high correlation between the methods.
Differences were mostly due to the database used and were
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less dependent on the calculation and normalization method.
Quantification based on sequence reads correlated highly with
a targeted quantitative PCR. Both fixed and random effects
models were subsequently used specifically to calculate the
selection pressure caused by ciprofloxacin on different groups
of ARGs. Interestingly, while positive selection was observed
for class D beta-lactamases, tetracyclines and macrolides
ARGs, there was also a substantial fraction of ARGs that
was negatively selected, most likely due to an eradication of
species harbouring these genes (e.g. class A beta-lactamases
and glycopeptides). Such amechanism has been demonstrated
in an infant cohort that was exposed to antibiotics and whose
stool samples were analysed through sequence-based
metagenomics. Here, the progression of the abundance of a
beta-lactamase gene correlated highly with the relative abun-
dance of Klebsiella pneumoniae under treatment. Thus, this
species was likely to carry this resistance gene [87].
Quantification based on sequence reads has the advantage that
it does not rely on a metagenomic assembly and would thus
also count low abundance genes. However, ARG specificity
depends on the mapping parameters, and stringent criteria
might still result in an underestimation of ARGs.
None of the ARG quantification approaches described
above has targeted resistance-conferring mutations within an
antibiotic target gene, also called target resistance alleles
(TRAs). Resistance to important antibiotics such as quino-
lones and rifampicin is partly or fully based on TRAs.
However, quantification of TRAs is an issue since sequence
reads that match to an antibiotic target gene but do not span a
TRA region are difficult to assign, as it remains unclear
whether they originate from a wild-type or mutated version
of the antibiotic target gene. Simply ignoring such sequence
reads might result in a severe bias. Field and Hershberg have
analysed metagenomic datasets from the Integrated Microbial
Genomes with Microbiom Samples database and determined
TRA frequency for quinolones (gyrA/parC), rifamycins
(rpoB) and streptomycin (rpsL) [88]. TRA frequencies for
quinolones were found to be high among all human datasets
(~40 %), though how much the administration of antibiotics
has impacted the results is unclear.
While it is assumed that a positive selection is mostly due
to enrichment of resistant species, administering antibiotics
might also directly impact the dissemination of ARGs by hor-
izontal gene transfer (HGT), which is the most common
mechanism for pathogens to acquire new resistance genes
(reviewed in [10]). HGT appears to occur 25-fold more fre-
quently between human-associated bacteria than among eco-
logically diverse non-human isolates [86]. Whereas conjuga-
tion has long been considered of crucial importance for the
dissemination of ARGs, recent studies suggest that transduc-
tion by bacteriophages might play a more important role than
previously recognized [10]; however, data from clinical stud-
ies remain limited. Abeles et al. compared the oral and faecal
viromes of four untreated healthy individuals and five individ-
uals who received intravenous antibiotics at two time points.
Although not significant, there was a trend toward a treatment-
induced expansion of ARGs in the faecal viromes, which was
not detected in the oral viromes. However, the five patients in
the treatment group received different combination therapies
composed of cefazolin, ceftazidime, trimethoprim/
sulfamethaxole, vancomycin, daptomycin and rifampicin,
which made the group very inhomogeneous. Unfortunately,
no baseline sample of the patients was obtained before the
start of the treatment, limiting the conclusions to be drawn
from this study [60].
These exemplary studies have revealed that important
attempts have been made in estimating the impact of anti-
biotics or in calculating selection pressure. Our goal must
be in producing more comparable studies with set stan-
dards for determining ARG abundance and selection pres-
sure. This would involve the following aspects: (i) Results
can only be compared when similar sequencing strategies
and pre-analytical procedures are used. (ii) A critical se-
quencing depth must be specified to avoid underestimation
of low abundant but clinically relevant ARGs. (iii) A con-
sensus must be found regarding a definition of clinically
relevant antimicrobial resistant genes. A classification of
ARGs according to their attributed risk, which is depen-
dent on their potential to be spread, or to their origin in
human pathogens, has already been suggested [89], but
needs to be extended for these types of studies. The deter-
mination of the human resistome without the availability of
valid information on the origin of ARGs or their environ-
ment might induce an over-usage of antimicrobials. This
problem will be overcome at least in part with the increas-
ing availability of long-range read technologies. For exam-
ple, a long-read technology has been successfully applied
in identifying the chikungunya virus [90]. (iv) Factors that
influence ARG counts in metagenomic datasets have been
identified (Fig. 2), but no standards exist for the normali-
zation of such counts. While efforts have been made to
develop adequate methods [91], data normalization must
take into account the impact size of each influencing factor
in order to produce an appropriate weighting.
Additionally, since it is known that the composition of the
human resistome varies between different countries [11, 40,
48], it can also be assumed that there are considerable varia-
tions between different regions or hospitals. It is thus not un-
likely that the impact of antibiotics can vary as well and can
even be highly dependent on the baseline resistome of an
individual or group of individuals in a certain environmental
setting. Therefore, therapeutic strategies that would consider
antibiotic selection pressure might need to be adapted for the
regional resistance epidemiology in a way of a Bpersonalized
public health^ concept to unleash fully the preventive poten-
tial in this fight against resistance.
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A practical and prospective workflow
The current limitations of translational metagenomic ap-
proaches are likely to be overcome in the future. Our contri-
bution to that future is to draft a practical workflow of how
metagenomics could be applied in hospitals and how the in-
dividual patient, the hospital and the public health system
could benefit from it (Fig. 3). At and after admission,
sequence-based metagenomics could be used for a routine
screening of clinically relevant ARGs in patient stool samples.
Relevant resistance in pathogens would lead to appropriate
infection control measures. Phylogenetic analyses of pathogen
genomes could contribute, when necessary, to outbreak man-
agement. Furthermore, in case of a subsequent nosocomial
infection, appropriate empirical treatment could be immedi-
ately administered.
Fig. 2 Factors influencing the antimicrobial resistance gene count.
Several factors have an impact on the resistance gene count [39, 91,
92]. Red arrows indicate a positive correlation, for instance an increase
in the antimicrobial resistance gene (ARG) length increases also the ARG
count. The blue arrows indicates a negative correlation, like the increase
in the size of the genome where the ARG is derived from lowers the
chance of the ARG to be found in the metagenome. Green arrows indi-
cate factors with a proven influence on the resistance gene count; how-
ever, the relationship cannot be easily quantified in terms of direction.
Grey arrows indicate factors which influence on the resistance gene count
have not been systematically investigated but are likely to have an impact
Fig. 3 Possibilities for future
implementation of metagenomics
in infection control and clinical
microbiology
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The initial sample taken at admission can serve as an ana-
lytical baseline. In the event that patients receive antibiotics
during their hospital stay, the impact of the treatment could be
investigated by a time series analysis of further samples. The
results would reflect the local situation and could be used to
design efficient antibiotic stewardship programs.
Apart from a routine screening process, metagenomics
could be applied in patients suspected of having an infection.
Pathogens as well as virulence factors, whose presence could
indicate the causality between an identified pathogen and the
clinical case, could be detected. ARGs on relevant pathogens
could be revealed and appropriate treatment promptly
delivered.
Such a workflow is likely to result in improved patient
treatment, in a more detailed epidemiological analysis of nos-
ocomial pathogens, in faster and potentially more reliable di-
agnostics, as well as in advances in hospital infection control
and thus potentially in a reduction in the spread of resistance.
Final remarks
Despite the enormous efforts already being made to extend
our understanding of the human resistome and its various
interactions with the environment, we only have preliminary
knowledge available to us for implementing strategies that
would efficiently counter the actual threat of resistance in
our hospitals. Metagenomic methods offer great potential
here, especially if we focus on their clinical applicability,
which is the major characteristic of what we call translational
metagenomics.
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